Loading stock…

EMS-CHEMIE HOLDING AG (EMSN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

EMS-CHEMIE HOLDING AG

EMSNMarket cap $24BPrice $1007.9

Country🇨🇭Switzerland

SectorMaterials

IndustryChemicals

Manufactures high-performance polymers and specialty chemicals used in cars, electronics, and industrial equipment worldwide. This Swiss company punches way above its size, supplying lightweight materials that automakers rely on to cut vehicle weight without sacrificing strength.

In Bastion Portfolios?

52W Return+39%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-2%2

Revenue Forecast

Rev CAGR (1y)-3%2

Rev CAGR (3y)+3%3

Rev CAGR (5y)+3%3

Earnings Forecast

EPS Growth Y+1+3%4

EPS Growth Y+2+4%5

EPS Growth Y+3+6%5

Quality

Margins

EBIT Margin30%9

Net Income Margin24%8

Free Cash Flow Margin28%9

Debt

Net Debt/EBITDA-1.210

Efficiency

ROE23%8

ROA19%10

Earnings Stability55

GEAR+AVERAGE60

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)382

P/E Ratio (Forward 3y)361

P/BV9.32

EV Multiples

EV/EBITDA Fwd281

EV/EBIT Fwd312

Yield

Free Cash Flow Yield2.8%4

Dividend Yield1.7%5

Momentum

Short term

1 month return+6%9

3 month return+24%10

YTD return+56%9

Mid term

Price vs 52wHigh100%10

1 year return+52%9

Long term

3 year return+46%5

5 year return+7%4

Risk Shield

Price Risk

Beta0.76

Volatility20%10

Free Cash Flow

Free Cash Flow Margin28%9

Free Cash Flow Yield2.8%4

Quality

ROCE26%9

Earnings Stability55

Net Debt/EBITDA-1.210

02Growth

Is it actually growing, and how fast?

EMSNEMS-CHEMIE HOLDING

Revenue FY25$2.4B

GROWTH RATING↗

WEAK16 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+3%4

EPS growth, FY27E+4%5

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 3%/yr from here.

Earnings are set to grow in step with sales (EPS about 4%/yr vs revenue 3%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 84% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

EMSNEMS-CHEMIE HOLDING

Total return Current142%

Price return Current98.5%

MOMENTUM RATING↗

VERY STRONG89 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+6%9

3-month return+24%10

YTD return+56%9

MID & LONG-TERM▾SCORE

% of 52-week high100%10

1-year return+52%9

3-year return+46%5

5-year return+7%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 52% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+6%), over three months (+24%) and so far this year (+56%).

WATCH

Average long-term results. Multi-year returns are middling (+46% over three years and +7% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on EMS-CHEMIE HOLDING. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

EMSNEMS-CHEMIE HOLDING

Revenue FY25$2.4B

GROWTH RATING↗

WEAK16 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+3%4

EPS growth, FY27E+4%5

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 3%/yr from here.

Earnings are set to grow in step with sales (EPS about 4%/yr vs revenue 3%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 84% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

EMSNEMS-CHEMIE HOLDING

Total return Current142%

Price return Current98.5%

MOMENTUM RATING↗

VERY STRONG89 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+6%9

3-month return+24%10

YTD return+56%9

MID & LONG-TERM▾SCORE

% of 52-week high100%10

1-year return+52%9

3-year return+46%5

5-year return+7%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 52% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+6%), over three months (+24%) and so far this year (+56%).

WATCH

Average long-term results. Multi-year returns are middling (+46% over three years and +7% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on EMS-CHEMIE HOLDING. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community